Skip to main content

Chiron Real Estate Inc.

corporate_fare Company Profile

Chiron Real Estate Inc.

XRN·NYSE·Real Estate & Construction·CIK 0001533615

Chiron Real Estate Inc. is a Maryland corporation and an internally managed REIT that primarily acquires healthcare facilities. These facilities are leased to physician groups and regional and national healthcare systems. The company's common stock is listed on the New York Stock Exchange. On February 23, 2026, the company changed its name from Global Medical REIT Inc. to Chiron Real Estate Inc. It elected to be taxed as a REIT for U.S. federal income tax purposes starting with its taxable year ended December 31, 2016. Chiron Real Estate Inc. holds its facilities and conducts operations through a Delaware limited partnership subsidiary, Chiron Real Estate LP. Its wholly owned subsidiary, Chiron Real Estate GP LLC, is the sole general partner of this Operating Partnership. As of December 31, 2025, Chiron Real Estate Inc. owned 92.0% of the outstanding common operating partnership units (OP Units) of its Operating Partnership. The remaining 8.0% of the Operating Partnership was owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services in exchange for OP Units. On September 19, 2025, the company completed a one-for-five reverse stock split of its outstanding common stock, with a corresponding adjustment to the outstanding partnership units of the Operating Partnership. The company's business strategy is to invest primarily in healthcare properties that offer an attractive rate of return relative to its cost of capital and are operated by profitable physician groups, regional or national healthcare systems, or combinations of these.

Chiron Real Estate Inc. (NYSE:XRN) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 24 items for XRN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for XRN spans 10-Q, 8-K, 8-K/A, S-3.

Recent high-impact activity:

  • Chiron Q3 Loss Widens to $5.7M as SHOP Transition Costs Bite; Liquidity $70.4M
  • Chiron Real Estate Posts $5.7M Q3 Net Loss as FFO Comes in at $7.3M
  • Chiron Closes $173.2M Pinnacle Acquisition, Adds $171M Debt
  • Chiron Files Audited Financials for $248.9M Senior Housing Acquisitions
  • Chiron Real Estate Reshuffles C-Suite, Names New COO and Head of Seniors Housing

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$148.21M
Net Income
-$6.88M
Diluted EPS
-$0.91
Op. Cash Flow
$73.61M
Cash & Equivalents
$9.08M
Total Debt
$1.15M
Debt / Equity
0.00×
Net Margin
-4.6%
Shares Outstanding
13.23M sh
Source: 10-K · filed 2026-03-02 · accession 0001104659-26-021956

Short Interest & Short Volume

3.65 days to cover

FINRA reported short interest of 942,609 shares in XRN as of the October 30, 2026 settlement, a 1.1% increase from the prior period — about 3.6 days to cover at its recent average daily volume. On November 20, 2026, 57.5% of XRN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)942,609 shares as of October 30, 2026
Change vs prior period▲ 1.1%
Days to cover3.65 at avg daily volume of 258,444
Daily short volume (FINRA facilities)57.5% of 91,285 shares on November 20, 2026
5-day average short volume53.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for XRN, detected from its recent SEC filings · based on capital-structure filings through 2026-06-16.

1 shelf registration

Resale Registration Filed · No Company Proceeds

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with X →
$25.47
52-week range · as of 2026-11-06 $25.47 – $38.65
Market cap
$369.97M
Volume
218.7K (1.0× avg)
3-mo avg 214.9K
Live data · 2026-11-21 12:34 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed XRN - Latest Insights

XRN
Nov 06, 2026, 4:42 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $28.70
Real-time Price: $25.47 info
Change: -$3.23 (-11%) info
Market Cap: $369.968M info
XRN
Nov 04, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $31.63
Real-time Price: $25.47 info
Change: -$6.16 (-19%) info
Market Cap: $369.968M info
XRN
Oct 05, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $33.81
Real-time Price: $25.47 info
Change: -$8.34 (-25%) info
Market Cap: $369.968M info
XRN
Aug 17, 2026, 4:51 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $36.37
Real-time Price: $25.47 info
Change: -$10.90 (-30%) info
Market Cap: $369.968M info
XRN
Jul 17, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.90
Real-time Price: $25.47 info
Change: -$12.43 (-33%) info
Market Cap: $369.968M info
XRN
Jul 06, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $38.05
Real-time Price: $25.47 info
Change: -$12.58 (-33%) info
Market Cap: $369.968M info
XRN
Jul 06, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.33
Real-time Price: $25.47 info
Change: -$11.86 (-32%) info
Market Cap: $369.968M info
XRN
Jul 02, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $37.97
Real-time Price: $25.47 info
Change: -$12.50 (-33%) info
Market Cap: $369.968M info
XRN
Jun 16, 2026, 5:11 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $35.94
Real-time Price: $25.47 info
Change: -$10.47 (-29%) info
Market Cap: $369.968M info
XRN
Jun 02, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.59
Real-time Price: $25.47 info
Change: -$10.12 (-28%) info
Market Cap: $369.968M info
XRN
Jun 01, 2026, 5:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $35.18
Real-time Price: $25.47 info
Change: -$9.71 (-28%) info
Market Cap: $369.968M info
XRN
May 20, 2026, 5:24 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $36.25
Real-time Price: $25.47 info
Change: -$10.78 (-30%) info
Market Cap: $369.968M info
XRN
May 08, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $33.99
Real-time Price: $25.47 info
Change: -$8.52 (-25%) info
Market Cap: $369.968M info
XRN
May 07, 2026, 5:25 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $32.30
Real-time Price: $25.47 info
Change: -$6.83 (-21%) info
Market Cap: $369.968M info
XRN
May 07, 2026, 4:35 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $32.30
Real-time Price: $25.47 info
Change: -$6.83 (-21%) info
Market Cap: $369.968M info
XRN
May 06, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $35.29
Real-time Price: $25.47 info
Change: -$9.82 (-28%) info
Market Cap: $369.968M info
XRN
May 06, 2026, 4:18 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $34.85
Real-time Price: $25.47 info
Change: -$9.38 (-27%) info
Market Cap: $369.968M info
XRN
Apr 08, 2026, 4:46 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $34.41
Real-time Price: $25.47 info
Change: -$8.94 (-26%) info
Market Cap: $369.968M info
XRN
Apr 08, 2026, 4:43 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $34.41
Real-time Price: $25.47 info
Change: -$8.94 (-26%) info
Market Cap: $369.968M info
XRN
Mar 12, 2026, 4:23 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $34.18
Real-time Price: $25.47 info
Change: -$8.71 (-25%) info
Market Cap: $369.968M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets